Study: Cognitive Markers or Biomarkers to manage Cognitive Health across the Lifespan?

By SharpBrains | September 12, 2011 |

Pre­dict­ing Alzheimer’s Dis­ease More Accu­rate Through Cog­ni­tive Changes Than Bio­mark­ers (Med­ical News): “Mea­sur­ing peo­ple’s changes in cog­ni­tive abil­i­ties is a bet­ter pre­dic­tor of Alzheimer’s dis­ease than changes in bio­mark­ers, researchers from the Ben­i­to Men­ni Com­plex Assis­ten­cial en Salut Men­tal, Barcelona, Spain, report­ed in Archives of Gen­er­al Psy­chi­a­try, a JAMA jour­nal.” “The inves­ti­ga­tors used a range of…

Read More

Intel Corporation and Lumos Labs Become Gold Sponsors of 2011 SharpBrains Summit

By Alvaro Fernandez | March 22, 2011

We are pleased to make eleven impor­tant announce­ments about the upcom­ing 2011 Sharp­Brains Vir­tu­al Sum­mit…eleven addi­tion­al rea­sons to con­sid­er reg­is­ter­ing and join­ing our event and com­mu­ni­ty next week. Intel Cor­po­ra­tion, the “Spon­sors of Tomor­row™”, and Lumos Labs have become Sum­mit Gold Spon­sors. Sharp­Brains will issue a Cer­tifi­cate of Atten­dance to par­tic­i­pants (20 hours of con­tin­u­ing edu­ca­tion). Jamie…

Read More